Melita Sun Jung

Insider Reports History

Entity
Individual
Location
C/O Structure Therapeutics Inc., South San Francisco, CA
Signature
/s/ David Strauss, as Attorney-in-Fact for Melita Sun Jung
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Melita Sun Jung:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Structure Therapeutics Inc. Chief Business Officer American Depositary Shares 1K $62.5K $62.46 Feb 7, 2023 Direct
Terns Pharmaceuticals, Inc. Chief Business Officer Common Stock 2.25K $11.5K $5.11 Nov 30, 2024 Direct
Terns Pharmaceuticals, Inc. Chief Business Officer Stock Option (Right to Buy) 325K Jan 30, 2025 Direct

Insider Reports Filed by Melita Sun Jung

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TERN Terns Pharmaceuticals, Inc. Jan 30, 2025 2 $11.5K 4 Feb 3, 2025 Chief Business Officer
TERN Terns Pharmaceuticals, Inc. May 1, 2024 1 $0 4 May 2, 2024 Chief Business Officer
TERN Terns Pharmaceuticals, Inc. Apr 22, 2024 0 $0 3 May 2, 2024 Chief Business Officer
GPCR Structure Therapeutics Inc. Feb 7, 2023 1 $15K 4 Feb 9, 2023 Chief Business Officer
GPCR Structure Therapeutics Inc. Feb 2, 2023 0 $0 3 Feb 2, 2023 Chief Business Officer